These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Diabetic ketoacidosis associated with clozapine treatment. Colli A; Cocciolo M; Francobandiera F; Rogantin F; Cattalini N Diabetes Care; 1999 Jan; 22(1):176-7. PubMed ID: 10333925 [No Abstract] [Full Text] [Related]
9. Diabetic ketoacidosis and severe hypertriglyceridaemia as a consequence of an atypical antipsychotic agent. Hepburn K; Brzozowska MM BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27507689 [TBL] [Abstract][Full Text] [Related]
10. [Screening of adults with schizophrenia for metabolic complications caused by atypical antipsychotics]. Cohen D Tijdschr Psychiatr; 2010; 52(2):111-5. PubMed ID: 20146182 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous side effects of both clozapine and valproate. Nicolai J; Smith SJ; Keunen RW Intensive Care Med; 2001 May; 27(5):943. PubMed ID: 11430560 [No Abstract] [Full Text] [Related]
12. Monitoring clozapine adverse effects calls for the integration of protocol and good clinical practice. Bak M J Clin Psychiatry; 2012 Oct; 73(10):1313-4. PubMed ID: 23140649 [No Abstract] [Full Text] [Related]
13. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis. Avram AM; Patel V; Taylor HC; Kirwan JP; Kalhan S Ann Pharmacother; 2001 Nov; 35(11):1381-7. PubMed ID: 11724088 [TBL] [Abstract][Full Text] [Related]
14. Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors. Nihalani ND; Tu X; Lamberti JS; Olson D; Olivares T; Costea GO; Tang W Ann Clin Psychiatry; 2007; 19(2):105-12. PubMed ID: 17612850 [TBL] [Abstract][Full Text] [Related]
15. Deaths from diabetic ketoacidosis after long-term clozapine treatment. Wehring HJ; Kelly DL; Love RC; Conley RR Am J Psychiatry; 2003 Dec; 160(12):2241-2. PubMed ID: 14638600 [No Abstract] [Full Text] [Related]
16. [Diabetes mellitus associated with atypical antipsychotic medications: case report and review of the literature]. Reis JS; Alvarenga T; Rosário PW; Menezes PA; Rocha Rdos S; Purisch S Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):488-93. PubMed ID: 17546250 [TBL] [Abstract][Full Text] [Related]
17. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Leslie DL; Rosenheck RA Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666 [TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature. Muench J; Carey M J Am Board Fam Pract; 2001; 14(4):278-82. PubMed ID: 11458971 [TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics and glycemia: a case report. Waldman JC; Yaren S Can J Psychiatry; 2002 Sep; 47(7):686-7. PubMed ID: 12355686 [No Abstract] [Full Text] [Related]
20. Near fatal ketoacidosis with olanzapine treatment. Straker D; Mendelowitz A; Karlin L Psychosomatics; 2002; 43(4):339-40. PubMed ID: 12189265 [No Abstract] [Full Text] [Related] [Next] [New Search]